Systematic review and meta-analysis reveals demographic diversity gaps in atopic dermatitis clinical trials, highlighting limitations in treatment generalizability.
Introduction/Objectives: Atopic dermatitis (AD) is a common inflammatory skin condition affecting diverse demographic groups. Clinical trials are crucial for evaluating interventions, but insufficient diversity in age, race, and ethnicity among participants can limit the generalizability of findings. This study aimed to examine the diversity of participants in AD clinical trials based on age, race, ethnicity, and sex.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: